Global Microarray Scanner and Sequencer Market Research Report 2024

Publication ID:

PB505248245

Publication Date:

May 6, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Microarray scanners are widely used in functional biology, cellomics, gene expression, and drug discovery research. Sequencers are devices for gene sequencing, exome sequencing, transcriptome sequencing, and sequencing of cell genomes and methylation arrays.
The global Microarray Scanner and Sequencer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Microarray Scanner and Sequencer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microarray Scanner and Sequencer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Microarray Scanner and Sequencer include Illumina, Agilent, Perkin Elmer, Molecular Devices, Thermo Fisher Scientific, Alphatron Marine, Huron Digital Pathology, Roche NimbleGen and CapitalBio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microarray Scanner and Sequencer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microarray Scanner and Sequencer.
Report Scope
The Microarray Scanner and Sequencer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microarray Scanner and Sequencer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microarray Scanner and Sequencer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Agilent
Perkin Elmer
Molecular Devices
Thermo Fisher Scientific
Alphatron Marine
Huron Digital Pathology
Roche NimbleGen
CapitalBio
LI-COR
BGI
Innopsys
Olympus
Segment by Type
Scanner
Sequencer
Segment by Application
Academic Research
Medical Diagnosis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microarray Scanner and Sequencer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microarray Scanner and Sequencer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Microarray Scanner and Sequencer Market Overview
1.1 Product Overview and Scope of Microarray Scanner and Sequencer
1.2 Microarray Scanner and Sequencer Segment by Type
1.2.1 Global Microarray Scanner and Sequencer Market Value Comparison by Type (2024-2030)
1.2.2 Scanner
1.2.3 Sequencer
1.3 Microarray Scanner and Sequencer Segment by Application
1.3.1 Global Microarray Scanner and Sequencer Market Value by Application: (2024-2030)
1.3.2 Academic Research
1.3.3 Medical Diagnosis
1.3.4 Other
1.4 Global Microarray Scanner and Sequencer Market Size Estimates and Forecasts
1.4.1 Global Microarray Scanner and Sequencer Revenue 2019-2030
1.4.2 Global Microarray Scanner and Sequencer Sales 2019-2030
1.4.3 Global Microarray Scanner and Sequencer Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Microarray Scanner and Sequencer Market Competition by Manufacturers
2.1 Global Microarray Scanner and Sequencer Sales Market Share by Manufacturers (2019-2024)
2.2 Global Microarray Scanner and Sequencer Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Microarray Scanner and Sequencer Average Price by Manufacturers (2019-2024)
2.4 Global Microarray Scanner and Sequencer Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microarray Scanner and Sequencer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microarray Scanner and Sequencer, Product Type & Application
2.7 Microarray Scanner and Sequencer Market Competitive Situation and Trends
2.7.1 Microarray Scanner and Sequencer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microarray Scanner and Sequencer Players Market Share by Revenue
2.7.3 Global Microarray Scanner and Sequencer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microarray Scanner and Sequencer Retrospective Market Scenario by Region
3.1 Global Microarray Scanner and Sequencer Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Microarray Scanner and Sequencer Global Microarray Scanner and Sequencer Sales by Region: 2019-2030
3.2.1 Global Microarray Scanner and Sequencer Sales by Region: 2019-2024
3.2.2 Global Microarray Scanner and Sequencer Sales by Region: 2025-2030
3.3 Global Microarray Scanner and Sequencer Global Microarray Scanner and Sequencer Revenue by Region: 2019-2030
3.3.1 Global Microarray Scanner and Sequencer Revenue by Region: 2019-2024
3.3.2 Global Microarray Scanner and Sequencer Revenue by Region: 2025-2030
3.4 North America Microarray Scanner and Sequencer Market Facts & Figures by Country
3.4.1 North America Microarray Scanner and Sequencer Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Microarray Scanner and Sequencer Sales by Country (2019-2030)
3.4.3 North America Microarray Scanner and Sequencer Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microarray Scanner and Sequencer Market Facts & Figures by Country
3.5.1 Europe Microarray Scanner and Sequencer Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Microarray Scanner and Sequencer Sales by Country (2019-2030)
3.5.3 Europe Microarray Scanner and Sequencer Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microarray Scanner and Sequencer Market Facts & Figures by Country
3.6.1 Asia Pacific Microarray Scanner and Sequencer Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Microarray Scanner and Sequencer Sales by Country (2019-2030)
3.6.3 Asia Pacific Microarray Scanner and Sequencer Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Microarray Scanner and Sequencer Market Facts & Figures by Country
3.7.1 Latin America Microarray Scanner and Sequencer Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Microarray Scanner and Sequencer Sales by Country (2019-2030)
3.7.3 Latin America Microarray Scanner and Sequencer Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microarray Scanner and Sequencer Market Facts & Figures by Country
3.8.1 Middle East and Africa Microarray Scanner and Sequencer Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Microarray Scanner and Sequencer Sales by Country (2019-2030)
3.8.3 Middle East and Africa Microarray Scanner and Sequencer Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Microarray Scanner and Sequencer Sales by Type (2019-2030)
4.1.1 Global Microarray Scanner and Sequencer Sales by Type (2019-2024)
4.1.2 Global Microarray Scanner and Sequencer Sales by Type (2025-2030)
4.1.3 Global Microarray Scanner and Sequencer Sales Market Share by Type (2019-2030)
4.2 Global Microarray Scanner and Sequencer Revenue by Type (2019-2030)
4.2.1 Global Microarray Scanner and Sequencer Revenue by Type (2019-2024)
4.2.2 Global Microarray Scanner and Sequencer Revenue by Type (2025-2030)
4.2.3 Global Microarray Scanner and Sequencer Revenue Market Share by Type (2019-2030)
4.3 Global Microarray Scanner and Sequencer Price by Type (2019-2030)
5 Segment by Application
5.1 Global Microarray Scanner and Sequencer Sales by Application (2019-2030)
5.1.1 Global Microarray Scanner and Sequencer Sales by Application (2019-2024)
5.1.2 Global Microarray Scanner and Sequencer Sales by Application (2025-2030)
5.1.3 Global Microarray Scanner and Sequencer Sales Market Share by Application (2019-2030)
5.2 Global Microarray Scanner and Sequencer Revenue by Application (2019-2030)
5.2.1 Global Microarray Scanner and Sequencer Revenue by Application (2019-2024)
5.2.2 Global Microarray Scanner and Sequencer Revenue by Application (2025-2030)
5.2.3 Global Microarray Scanner and Sequencer Revenue Market Share by Application (2019-2030)
5.3 Global Microarray Scanner and Sequencer Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Illumina
6.1.1 Illumina Corporation Information
6.1.2 Illumina Description and Business Overview
6.1.3 Illumina Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Illumina Microarray Scanner and Sequencer Product Portfolio
6.1.5 Illumina Recent Developments/Updates
6.2 Agilent
6.2.1 Agilent Corporation Information
6.2.2 Agilent Description and Business Overview
6.2.3 Agilent Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Agilent Microarray Scanner and Sequencer Product Portfolio
6.2.5 Agilent Recent Developments/Updates
6.3 Perkin Elmer
6.3.1 Perkin Elmer Corporation Information
6.3.2 Perkin Elmer Description and Business Overview
6.3.3 Perkin Elmer Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Perkin Elmer Microarray Scanner and Sequencer Product Portfolio
6.3.5 Perkin Elmer Recent Developments/Updates
6.4 Molecular Devices
6.4.1 Molecular Devices Corporation Information
6.4.2 Molecular Devices Description and Business Overview
6.4.3 Molecular Devices Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Molecular Devices Microarray Scanner and Sequencer Product Portfolio
6.4.5 Molecular Devices Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Corporation Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Thermo Fisher Scientific Microarray Scanner and Sequencer Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Alphatron Marine
6.6.1 Alphatron Marine Corporation Information
6.6.2 Alphatron Marine Description and Business Overview
6.6.3 Alphatron Marine Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Alphatron Marine Microarray Scanner and Sequencer Product Portfolio
6.6.5 Alphatron Marine Recent Developments/Updates
6.7 Huron Digital Pathology
6.6.1 Huron Digital Pathology Corporation Information
6.6.2 Huron Digital Pathology Description and Business Overview
6.6.3 Huron Digital Pathology Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Huron Digital Pathology Microarray Scanner and Sequencer Product Portfolio
6.7.5 Huron Digital Pathology Recent Developments/Updates
6.8 Roche NimbleGen
6.8.1 Roche NimbleGen Corporation Information
6.8.2 Roche NimbleGen Description and Business Overview
6.8.3 Roche NimbleGen Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche NimbleGen Microarray Scanner and Sequencer Product Portfolio
6.8.5 Roche NimbleGen Recent Developments/Updates
6.9 CapitalBio
6.9.1 CapitalBio Corporation Information
6.9.2 CapitalBio Description and Business Overview
6.9.3 CapitalBio Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CapitalBio Microarray Scanner and Sequencer Product Portfolio
6.9.5 CapitalBio Recent Developments/Updates
6.10 LI-COR
6.10.1 LI-COR Corporation Information
6.10.2 LI-COR Description and Business Overview
6.10.3 LI-COR Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.10.4 LI-COR Microarray Scanner and Sequencer Product Portfolio
6.10.5 LI-COR Recent Developments/Updates
6.11 BGI
6.11.1 BGI Corporation Information
6.11.2 BGI Microarray Scanner and Sequencer Description and Business Overview
6.11.3 BGI Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BGI Microarray Scanner and Sequencer Product Portfolio
6.11.5 BGI Recent Developments/Updates
6.12 Innopsys
6.12.1 Innopsys Corporation Information
6.12.2 Innopsys Microarray Scanner and Sequencer Description and Business Overview
6.12.3 Innopsys Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Innopsys Microarray Scanner and Sequencer Product Portfolio
6.12.5 Innopsys Recent Developments/Updates
6.13 Olympus
6.13.1 Olympus Corporation Information
6.13.2 Olympus Microarray Scanner and Sequencer Description and Business Overview
6.13.3 Olympus Microarray Scanner and Sequencer Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Olympus Microarray Scanner and Sequencer Product Portfolio
6.13.5 Olympus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microarray Scanner and Sequencer Industry Chain Analysis
7.2 Microarray Scanner and Sequencer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microarray Scanner and Sequencer Production Mode & Process
7.4 Microarray Scanner and Sequencer Sales and Marketing
7.4.1 Microarray Scanner and Sequencer Sales Channels
7.4.2 Microarray Scanner and Sequencer Distributors
7.5 Microarray Scanner and Sequencer Customers
8 Microarray Scanner and Sequencer Market Dynamics
8.1 Microarray Scanner and Sequencer Industry Trends
8.2 Microarray Scanner and Sequencer Market Drivers
8.3 Microarray Scanner and Sequencer Market Challenges
8.4 Microarray Scanner and Sequencer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Illumina
Agilent
Perkin Elmer
Molecular Devices
Thermo Fisher Scientific
Alphatron Marine
Huron Digital Pathology
Roche NimbleGen
CapitalBio
LI-COR
BGI
Innopsys
Olympus

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂